Clinical Trials List
Protocol NumberTCD16210
Completed
2020-07-01 - 2022-05-01
Phase I/II
Recruiting2
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- James Chih-Hsin Yang Division of Hematology & Oncology
- Chong-Jen Yu Division of Hematology & Oncology
- 蔡子修 Division of Hematology & Oncology
- 梁逸歆 Division of Hematology & Oncology
- Hsin-Yu Liu Division of Ophthalmology
- 徐偉勛 Division of Hematology & Oncology
- CHAO-CHI HO CHAO-CHI HO Division of Hematology & Oncology
- 楊景堯 Division of Hematology & Oncology
- TSUNG-HAO LIU Division of Hematology & Oncology
- 廖斌志 Division of Hematology & Oncology
- 廖唯昱 Division of Hematology & Oncology
- 吳尚俊 Division of Hematology & Oncology
- YEN-TING LIN Division of Hematology & Oncology
- Jih-Hsiang Lee Division of Hematology & Oncology
- JIN-YUAN SHIH Division of Hematology & Oncology
- 許嘉林 Division of Hematology & Oncology
- 郭弘揚 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shang-Hung Chen Division of Hematology & Oncology
- Wu-Chou Su Division of Hematology & Oncology
- Shang-Yin Wu Division of Hematology & Oncology
- Peng-Chan Lin Division of Hematology & Oncology
- Jui-Hung Tsai Division of Hematology & Oncology
- Po-Wen Lin Division of Colorectal Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
24 participants
